§ BIOTECHNOLOGY
USD · Biotechnology

CRBU

CARIBOU BIOSCIENCES INC
USDSector · Biotechnology
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
73 increased/new, 26 decreased/exited (13F)
AC 13F Analysis
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
Pfizer Inc4.7M3.5%±0%
VANGUARD CAPITAL MANAGEMENT LLC3.8Mn/an/a
Renaissance Technologies2.6M0.0%+58%
Kynam Capital Management, LP2.5M0.3%±0%
BlackRock, Inc.2.1M0.0%+0%
TWO SIGMA INVESTMENTS, LP1.8M0.0%+73%
◇ AC INTELLIGENCE

Top institutional owners for CRBU as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER56.4% · 0 holders
OTHER26.7% · 94 holders
PASSIVE / INDEX4.1% · 6 holders
SYSTEMATIC / QUANT4.0% · 4 holders
QUALITY / COMPOUNDER3.9% · 9 holders
DEALER / BANK3.5% · 19 holders
TACTICAL / MACRO1.4% · 2 holders
INCOME / DEFENSIVE0.1% · 2 holders
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for CRBU in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention CRBU yet.